BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 21694582)

  • 1. Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.
    Arita J; Takahashi M; Hata S; Shindoh J; Beck Y; Sugawara Y; Hasegawa K; Kokudo N
    Ann Surg; 2011 Dec; 254(6):992-9. PubMed ID: 21694582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
    Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
    AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of sonazoid-ultrasonography during hepatectomy in patients with liver tumors: A preliminary study.
    Nanashima A; Tobinaga S; Abo T; Kunizaki M; Takeshita H; Hidaka S; Taura N; Ichikawa T; Sawai T; Nakao K; Nagayasu T
    J Surg Oncol; 2011 Feb; 103(2):152-7. PubMed ID: 21259249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact.
    Mitsunori Y; Tanaka S; Nakamura N; Ban D; Irie T; Noguchi N; Kudo A; Iijima H; Arii S
    J Hepatobiliary Pancreat Sci; 2013 Feb; 20(2):234-42. PubMed ID: 22399158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma.
    Kudo M; Hatanaka K; Maekawa K
    Oncology; 2010 Jul; 78 Suppl 1():40-5. PubMed ID: 20616583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma.
    Masuzaki R; Shiina S; Tateishi R; Yoshida H; Goto E; Sugioka Y; Kondo Y; Goto T; Ikeda H; Omata M; Koike K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):759-64. PubMed ID: 21054516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid.
    Hatanaka K; Kudo M; Minami Y; Ueda T; Tatsumi C; Kitai S; Takahashi S; Inoue T; Hagiwara S; Chung H; Ueshima K; Maekawa K
    Intervirology; 2008; 51 Suppl 1():61-9. PubMed ID: 18544950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced intraoperative ultrasonography in surgery for hepatocellular carcinoma in cirrhosis.
    Torzilli G; Olivari N; Moroni E; Del Fabbro D; Gambetti A; Leoni P; Montorsi M; Makuuchi M
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S34-8. PubMed ID: 14762837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced intraoperative ultrasonography equipped with late Kupffer-phase image obtained by sonazoid in patients with colorectal liver metastases.
    Nakano H; Ishida Y; Hatakeyama T; Sakuraba K; Hayashi M; Sakurai O; Hataya K
    World J Gastroenterol; 2008 May; 14(20):3207-11. PubMed ID: 18506927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography.
    Maruyama H; Takahashi M; Ishibashi H; Okugawa H; Okabe S; Yoshikawa M; Yokosuka O
    Liver Int; 2009 May; 29(5):708-14. PubMed ID: 18803588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound: Improving the preoperative staging of hepatocellular carcinoma and guiding individual treatment.
    Zhang XY; Luo Y; Wen TF; Jiang L; Li C; Zhong XF; Zhang JY; Ling WW; Yan LN; Zeng Y; Wu H
    World J Gastroenterol; 2014 Sep; 20(35):12628-36. PubMed ID: 25253968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the post-vascular phase of contrast-enhanced ultrasonography with sonazoid in the evaluation of gross types of hepatocellular carcinoma.
    Hatanaka K; Chung H; Kudo M; Haji S; Minami Y; Maekawa K; Hayaishi S; Nagai T; Takita M; Kudo K; Ueda T; Tatsumi C; Kitai S; Ishikawa E; Yada N; Inoue T; Hagiwara S; Ueshima K
    Oncology; 2010 Jul; 78 Suppl 1():53-9. PubMed ID: 20616585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in tumor vascularity precede microbubble contrast accumulation deficit in the process of dedifferentiation of hepatocellular carcinoma.
    Maruyama H; Takahashi M; Ishibashi H; Okabe S; Yoshikawa M; Yokosuka O
    Eur J Radiol; 2010 Jul; 75(1):e102-6. PubMed ID: 19783392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma.
    Goto E; Masuzaki R; Tateishi R; Kondo Y; Imamura J; Goto T; Ikeda H; Akahane M; Shiina S; Omata M; Yoshida H; Koike K
    J Gastroenterol; 2012 Apr; 47(4):477-85. PubMed ID: 22200940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Matsueda K; Saiura A
    Ann Surg; 2015 Dec; 262(6):1086-91. PubMed ID: 26010441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New contrast enhanced ultrasonography agent: impact of Sonazoid on radiofrequency ablation.
    Hiraoka A; Hiasa Y; Onji M; Michitaka K
    J Gastroenterol Hepatol; 2011 Apr; 26(4):616-8. PubMed ID: 21418298
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.
    Luo W; Numata K; Morimoto M; Nozaki A; Nagano Y; Sugimori K; Zhou X; Tanaka K
    Eur J Radiol; 2009 Dec; 72(3):425-31. PubMed ID: 18930616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of contrast-enhanced sonography of small hepatocellular carcinoma with sonazoid prior to radiofrequency ablation.
    Lee SJ; Won HJ; Kim KW; Shin YM; Kim PN
    J Clin Ultrasound; 2017 Sep; 45(7):383-390. PubMed ID: 28271531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.